Rick Modi
Algemeen Directeur bij Affinia Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Rick Modi
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
28
| Subsidiary | Biotechnology | 28 |
26
| Extinct | Biotechnology | 26 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA.
17
| Holding Company | Biotechnology | 17 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.
16
| Subsidiary | Medical Specialties | 16 |
| Subsidiary | Biotechnology | 14 | |
| Public Company | Pharmaceuticals: Major | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Rick Modi via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal President President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member President Founder | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Investor Relations Contact | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing Sales & Marketing Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NOVAVAX, INC. | Biotechnology | Director/Board Member Chairman President Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Director/Board Member Graduate Degree Undergraduate Degree | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Founder Private Equity Investor President Private Equity Investor | |
| NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Director/Board Member | |
| University of Notre Dame | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Director/Board Member Chief Operating Officer Chairman | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| University of Pennsylvania | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Founder Director/Board Member Founder | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| AKOUOS | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Yale University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal President | |
| AXCA HEALPAR | Biotechnology | Director of Finance/CFO Director/Board Member | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 4 |
| Zwitserland | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 13 |
| Finance | 4 |
| Commercial Services | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 537 |
| Corporate Officer/Principal | 236 |
| Independent Dir/Board Member | 202 |
| Undergraduate Degree | 87 |
| Chairman | 86 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Ed Mathers Mathers | 47 |
| David Mott | 45 |
| Jonathan Leff | 45 |
| Tony Vernon | 34 |
| Peter Greenleaf | 31 |
| David Kabakoff | 30 |
| Carole Nüchterlein | 26 |
| Julie McHugh | 26 |
| Paul Manning | 26 |
| Daniel Welch | 24 |
| Dave Grayzel | 23 |
| Burt Adelman | 23 |
| Jean-Jacques Bienaimé | 21 |
| Stephen D. Chubb | 20 |
